semaglutide for heart disease FDA Approves Wegovy to Reduce and Stroke Risk in People With Obesity Weight loss drug Wegovy helps

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (Mounjaro) and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities (Zepbound)

Our team in Melbourne serves clients throughout Brevard County with holistic, science-driven care

When combined with GLP-1 and GIP activation, glucagon signaling may increase calorie burning in addition to reducing appetite

This powerful treatment is available at both our Buda and Kyle locations, making it convenient to start your transformation close to home